Clorox (CLX) Tops Q1 EPS by 4c, Trims FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Clorox Reports Q1 Fiscal Year 2019 Results, Updates FY19 Outlook
October 31, 2018 6:30 AM EDTOAKLAND, Calif., Oct. 31, 2018 /PRNewswire/ --Â The Clorox Company (NYSE: CLX) reported sales growth of 4 percent and an 11 percent increase in diluted net earnings per share from continuing operations (diluted EPS) for its first quarter of fiscal year 2019, which ended Sept. 30, 2018.
"I'm pleased that we delivered a solid first quarter with strong sales and earnings growth," said Clorox Chair and CEO Benno Dorer. "We're sustaining sales momentum behind superior consumer value supported by innovation. What's more, our pricing actions and cost savings initiatives are helping us counter stronger near-term... More



